Close
ACHEMA MIDDLE EAST 2026

Care Access Research Launches Alliance to Provide Infrastructure for COVID-19 Trials

As the COVID-19 pandemic continues globally, biopharma companies have rushed to develop vaccines, new drugs and repurpose old drugs in an attempt to slow,...

Almac Clinical Technologies Announces Expedited Support for COVID-19 Clinical Trials

Almac Clinical Technologies, a member of the Almac Group, has announced the expedited deployment and support of multiple Interactive Response Technology (IRT) solutions in...

Regeneron, Zai Lab Announce Regional Collaboration for REGN1979

Regeneron Pharmaceuticals and Zai Lab announced a strategic collaboration for the development and commercialization of REGN1979 (CD20xCD3 bispecific antibody) in mainland China, Hong Kong,...

CROMSOURCE Announces Launch of COVID-19 Clinical Trial

CROMSOURCE has announced that it has initiated its first COVID-19 trial on behalf of a European pharmaceutical company. This trial is expected to be...

Global COVID-19 Clinical Trial Tracker Launched by Cytel

Cytel Inc. has launched an open-access global COVID-19 Clinical Trial Tracker to help facilitate greater collaboration between researchers, policymakers, clinicians, journalists, philanthropists, and other...

Incyte Announces Plans to Initiate a Phase 3 Clinical Trial of Ruxolitinib as a Treatment for Patients with COVID-19 Associated Cytokine Storm

Incyte announced the Company is working with the U.S. FDA to initiate a Phase 3 clinical trial (RUXCOVID) to evaluate the efficacy and safety...

Mateon Achieves Milestone in its Development of OT-101, a Phase 3 Clinical Drug Candidate, Against COVID-19

Mateon Therapeutics, Inc dedicated to development OT-101, a TGF-β antisense drug candidate, announced that Mateon has delivered the requisite testing results to Golden Mountain...

Subscribe Our Newsletter

White Papers

The Future of Digital Health

The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....

Five Best Practices to Deliver Exceptional Multichannel Experiences

A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...

The Impact and Use of Social Media in Pharmacovigilance

Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...